Agilent showcases comprehensive cancer portfolio solutions at aacr 2023

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a) announced today that it will highlight new cell analysis, genomics, digital pathology, and companion diagnostics solutions at the american association for cancer research annual meeting, held april 14-19, 2023, in orlando, florida. cancer is the second most common cause of death in the us, and the incidence continues to increase, with over 1.9 million new cancer cases expected to be diagnosed in 2023.
A Ratings Summary
A Quant Ranking